DYAI
Dyadic International, Inc.
Price Chart
Latest Quote
$1.26
+0.07 (+5.88%)
Current Price
| Previous Close | $1.19 |
| Open | $1.17 |
| Day High | $1.30 |
| Day Low | $1.17 |
| Volume | 135,482 |
Stock Information
| Shares Outstanding | 36.44M |
| Total Debt | $5.05M |
| Cash Equivalents | $5.61M |
| Revenue | $3.81M |
| Net Income | $-7.29M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $45.91M |
| EPS (TTM) | $-0.22 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $45.36M |
| Sales | $3.81M |
| Income | $-7.29M |
| Book/sh | $-0.01 |
| Cash/sh | $0.15 |
| Employees | 5 |
Financial Ratios
| Quick Ratio | 2.08 |
| Current Ratio | 2.42 |
Returns & Margins
| ROA | -56.22% |
| ROE | -2826.92% |
| Gross Margin | 26.10% |
| Operating Margin | -172.13% |
| Profit Margin | -191.50% |
Ownership
| Insider Ownership | 25.53% |
| Institutional Ownership | 14.96% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.94 |
| P/S | 12.06 |
| P/B | -114.55 |
Analyst Data
| Recommendation | none |
| Target Price | $6.00 |
Technical Indicators
| SMA20 | $0.97 |
| SMA50 | $0.83 |
| SMA200 | $0.89 |
| RSI | 75.56 |
| ATR | 0.1286 |
| Shares Float | 27.37M |
| Short Float | 0.57% |
| Short Ratio | 0.90 |
| Volatility | 1.15 |
| Rel Volume | 0.52 |
Performance History
| Week | +18.87% |
| Month | +61.54% |
| Quarter | +43.18% |
| 6 Months | +43.18% |
| YTD | +34.04% |
| Year | +28.57% |
| 3 Years | -32.62% |
| 5 Years | -65.00% |
| 10 Years | -22.22% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $1.26 | 136,000 |
| 2026-07-16 | $1.19 | 104,500 |
| 2026-07-15 | $1.22 | 254,800 |
| 2026-07-14 | $1.21 | 771,900 |
| 2026-07-13 | $1.02 | 218,300 |
| 2026-07-10 | $1.06 | 95,700 |
| 2026-07-09 | $1.07 | 156,800 |
| 2026-07-08 | $1.00 | 213,100 |
| 2026-07-07 | $1.06 | 1,120,200 |
| 2026-07-06 | $0.97 | 45,100 |
| 2026-07-02 | $0.94 | 97,300 |
| 2026-07-01 | $1.02 | 310,100 |
| 2026-06-30 | $0.90 | 147,600 |
| 2026-06-29 | $0.88 | 124,300 |
| 2026-06-26 | $0.80 | 395,400 |
| 2026-06-25 | $0.74 | 571,500 |
| 2026-06-24 | $0.73 | 71,800 |
| 2026-06-23 | $0.81 | 79,500 |
| 2026-06-22 | $0.78 | 80,600 |
| 2026-06-18 | $0.78 | 217,400 |
About Dyadic International, Inc.
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
đ° Latest News
Dyadic (DYAI) Q1 2026 Earnings Call Transcript
Motley Fool âĸ 2026-06-02T16:39:07Z
Dyadic International, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-14T12:30:00Z
Dyadic International Inc (DYAI) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...
GuruFocus.com âĸ 2026-05-14T05:01:38ZTranscript: Dyadic International Q1 2026 Earnings Conference Call
Benzinga âĸ 2026-05-13T21:54:33Z
Analysts Expect Breakeven For Dyadic International, Inc. (NASDAQ:DYAI) Before Long
Simply Wall St. âĸ 2026-03-28T12:28:04Z
Dyadic International Inc (DYAI) Q4 2025 Earnings Call Highlights: Navigating Transition with ...
GuruFocus.com âĸ 2026-03-26T03:00:48ZDyadic International, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-26T00:15:22Z
Dyadic (DYAI) Q4 2025 Earnings Call Transcript
Motley Fool âĸ 2026-03-25T22:23:53Z
Dyadic (DYAI) Q3 2025 Earnings Call Transcript
Motley Fool âĸ 2025-11-13T17:37:03Z
Dyadic International Inc (DYAI) Q3 2025 Earnings Call Highlights: Transition to Commercial ...
GuruFocus.com âĸ 2025-11-13T05:03:40Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,319,860 | $1,194,624 | $1,975,849 | $2,123,193 |
| Cost Of Revenue | $2,319,860 | $1,194,624 | $1,975,849 | $2,123,193 |
| Total Revenue | $1,232,311 | $3,495,389 | $2,898,806 | $2,930,303 |
| Operating Revenue | $1,232,311 | $3,495,389 | $2,898,806 | $2,930,303 |
| Expenses | ||||
| Interest Expense | $455,897 | $427,971 | $0 | - |
| Total Expenses | $8,378,227 | $9,373,650 | $11,090,128 | $13,046,063 |
| Other Income Expense | $-46,900 | $40,081 | $979,175 | $200,082 |
| Net Non Operating Interest Income Expense | $-171,812 | $29,021 | $416,686 | $180,420 |
| Interest Expense Non Operating | $455,897 | $427,971 | $0 | - |
| Operating Expense | $6,058,367 | $8,179,026 | $9,114,279 | $10,922,870 |
| Other Operating Expenses | $-1,858,034 | - | - | - |
| General And Administrative Expense | $5,761,735 | $6,134,773 | $5,817,013 | $6,421,505 |
| Other Non Operating Income Expenses | - | - | - | $250,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Net Interest Income | $-171,812 | $29,021 | $416,686 | $180,420 |
| Interest Income | $284,085 | $456,992 | $416,686 | $180,420 |
| Normalized Income | $-7,317,728 | $-5,849,240 | $-7,774,636 | $-9,685,340 |
| Net Income From Continuing And Discontinued Operation | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Total Operating Income As Reported | $-7,192,816 | $-5,900,822 | $-8,229,739 | $-10,165,678 |
| Net Income Common Stockholders | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Net Income | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Net Income Including Noncontrolling Interests | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Net Income Continuous Operations | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Pretax Income | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Special Income Charges | $0 | $62,642 | $1,017,592 | $0 |
| Interest Income Non Operating | $284,085 | $456,992 | $416,686 | $180,420 |
| Operating Income | $-7,145,916 | $-5,878,261 | $-8,191,322 | $-10,115,760 |
| Gross Profit | $-1,087,549 | $2,300,765 | $922,957 | $807,110 |
| Per Share | ||||
| Diluted EPS | $-0.23 | $-0.20 | $-0.24 | $-0.34 |
| Basic EPS | $-0.23 | $-0.20 | $-0.24 | $-0.34 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,861,831 | $-5,421,269 | $-7,774,636 | $-10,065,842 |
| Total Unusual Items | $-46,900 | $40,081 | $979,175 | $-49,918 |
| Total Unusual Items Excluding Goodwill | $-46,900 | $40,081 | $979,175 | $-49,918 |
| EBITDA (Bullshit earnings) | $-6,908,731 | $-5,381,188 | $-6,795,461 | $-10,115,760 |
| EBIT | $-6,908,731 | $-5,381,188 | $-6,795,461 | $-10,115,760 |
| Diluted Average Shares | $32,624,323 | $29,318,123 | $28,798,833 | $28,364,482 |
| Basic Average Shares | $32,624,323 | $29,318,123 | $28,798,833 | $28,364,482 |
| Diluted NI Availto Com Stockholders | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Gain On Sale Of Business | $0 | $62,642 | $1,017,592 | $0 |
| Gain On Sale Of Security | $-46,900 | $-22,561 | $-38,417 | $-49,918 |
| Research And Development | $2,154,666 | $2,044,253 | $3,297,266 | $4,501,365 |
| Selling General And Administration | $5,761,735 | $6,134,773 | $5,817,013 | $6,421,505 |
| Other Gand A | $5,761,735 | $6,134,773 | $5,817,013 | $6,421,505 |
| Tax Provision | - | - | - | - |
Fetched: 2026-07-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,232,410 | $2,470,290 | $5,878,585 | $11,087,739 |
| Total Assets | $9,945,725 | $9,930,275 | $8,219,236 | $13,712,818 |
| Total Non Current Assets | $49,072 | $102,607 | $151,901 | $290,754 |
| Other Non Current Assets | $10,537 | $10,396 | $10,462 | $6,045 |
| Current Assets | $9,896,653 | $9,827,668 | $8,067,335 | $13,422,064 |
| Restricted Cash | $1,231,168 | $0 | - | - |
| Prepaid Assets | $219,067 | $303,066 | $327,775 | $392,236 |
| Receivables | $1,125,426 | $261,275 | $476,242 | $388,286 |
| Other Receivables | $602,556 | $63,034 | $55,542 | $214,532 |
| Accrued Interest Receivable | $35,129 | $24,248 | $10,083 | $58,285 |
| Accounts Receivable | $487,741 | $173,993 | $410,617 | $115,469 |
| Cash Cash Equivalents And Short Term Investments | $7,320,992 | $9,263,327 | $7,263,318 | $12,641,542 |
| Cash And Cash Equivalents | $4,622,331 | $6,506,750 | $6,515,028 | $5,794,272 |
| Other Current Assets | - | $303,066 | $327,775 | - |
| Cash Equivalents | - | $5,580,463 | $6,489,253 | $5,767,490 |
| Cash Financial | - | $926,287 | $25,775 | $26,782 |
| Debt | ||||
| Net Debt | $403,713 | - | - | - |
| Total Debt | $5,060,665 | $5,066,217 | $136,929 | $0 |
| Long Term Debt And Capital Lease Obligation | $5,026,044 | $5,011,968 | $88,870 | $0 |
| Long Term Debt | $5,026,044 | $4,977,347 | - | - |
| Current Debt And Capital Lease Obligation | $34,621 | $54,249 | $48,059 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,713,315 | $7,459,985 | $2,340,651 | $2,625,079 |
| Total Non Current Liabilities Net Minority Interest | $5,026,044 | $5,011,968 | $88,870 | $176,471 |
| Current Liabilities | $3,687,271 | $2,448,017 | $2,251,781 | $2,448,608 |
| Current Deferred Liabilities | $1,730,852 | $833,813 | $490,113 | $217,214 |
| Payables And Accrued Expenses | $1,526,339 | $1,063,049 | $1,713,609 | $2,231,394 |
| Interest Payable | $101,800 | $107,173 | $0 | - |
| Payables | $852,024 | $482,320 | $656,445 | $1,276,313 |
| Accounts Payable | $852,024 | $482,320 | $656,445 | $1,276,313 |
| Other Current Liabilities | - | $1 | - | - |
| Non Current Deferred Liabilities | - | - | $0 | $176,471 |
| Equity | ||||
| Common Stock Equity | $1,232,410 | $2,470,290 | $5,878,585 | $11,087,739 |
| Total Equity Gross Minority Interest | $1,232,410 | $2,470,290 | $5,878,585 | $11,087,739 |
| Stockholders Equity | $1,232,410 | $2,470,290 | $5,878,585 | $11,087,739 |
| Retained Earnings | $-93,451,108 | $-86,086,480 | $-80,277,321 | $-73,481,860 |
| Long Term Equity Investment | - | - | $0 | $284,709 |
| Other | ||||
| Treasury Shares Number | $12,253,502 | $12,253,502 | $12,253,502 | $12,253,502 |
| Ordinary Shares Number | $36,187,798 | $29,835,799 | $28,811,061 | $28,563,100 |
| Share Issued | $48,441,300 | $42,089,301 | $41,064,563 | $40,816,602 |
| Tangible Book Value | $1,232,410 | $2,470,290 | $5,878,585 | $11,087,739 |
| Invested Capital | $6,258,454 | $7,447,637 | $5,878,585 | $11,087,739 |
| Working Capital | $6,209,382 | $7,379,651 | $5,815,554 | $10,973,456 |
| Capital Lease Obligations | $34,621 | $88,870 | $136,929 | $0 |
| Total Capitalization | $6,258,454 | $7,447,637 | $5,878,585 | $11,087,739 |
| Treasury Stock | $18,929,915 | $18,929,915 | $18,929,915 | $18,929,915 |
| Additional Paid In Capital | $113,564,991 | $107,444,595 | $105,044,756 | $103,458,697 |
| Capital Stock | $48,442 | $42,090 | $41,065 | $40,817 |
| Common Stock | $48,442 | $42,090 | $41,065 | $40,817 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $34,621 | $88,870 | $0 |
| Current Capital Lease Obligation | $34,621 | $54,249 | $48,059 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $395,459 | $496,905 | - | $580,264 |
| Current Accrued Expenses | $674,315 | $580,729 | $1,057,164 | $955,081 |
| Net PPE | $38,535 | $92,211 | $141,439 | $0 |
| Gross PPE | $38,535 | $92,211 | $141,439 | $0 |
| Other Properties | $38,535 | $92,211 | $141,439 | - |
| Other Short Term Investments | $2,698,661 | $2,756,577 | $748,290 | $6,847,270 |
| Non Current Deferred Revenue | - | - | $0 | $176,471 |
| Current Deferred Revenue | - | - | $0 | $176,471 |
| Investments And Advances | - | - | $0 | $284,709 |
Fetched: 2026-07-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,702,221 | $-3,974,806 | $-6,726,755 | $-8,083,775 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,702,221 | $-3,974,806 | $-6,726,755 | $-8,083,775 |
| Cash Flow From Continuing Operating Activities | $-5,702,221 | $-3,974,806 | $-6,726,755 | $-8,083,775 |
| Operating Gains Losses | $46,901 | $-38,416 | $-979,174 | $49,918 |
| Investing Activities | ||||
| Investing Cash Flow | $82,085 | $-1,876,253 | $7,449,896 | $-2,369,280 |
| Cash Flow From Continuing Investing Activities | $82,085 | $-1,876,253 | $7,449,896 | $-2,369,280 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,940,695 | $0 | - | - |
| Financing Cash Flow | $4,964,944 | $5,848,577 | $0 | $543,591 |
| Cash Flow From Continuing Financing Activities | $4,964,944 | $5,848,577 | $0 | $543,591 |
| Net Common Stock Issuance | $4,940,695 | $0 | - | - |
| Common Stock Issuance | $4,940,695 | $0 | - | - |
| Other | ||||
| Issuance Of Debt | $0 | $5,824,326 | $0 | - |
| Interest Paid Supplemental Data | $412,573 | $257,778 | $0 | - |
| End Cash Position | $5,853,499 | $6,506,750 | $6,515,028 | $5,794,272 |
| Beginning Cash Position | $6,506,750 | $6,515,028 | $5,794,272 | $15,748,480 |
| Effect Of Exchange Rate Changes | $1,941 | $-5,796 | $-2,385 | $-44,744 |
| Changes In Cash | $-655,192 | $-2,482 | $723,141 | $-9,909,464 |
| Proceeds From Stock Option Exercised | $24,249 | $24,251 | $0 | $543,591 |
| Net Issuance Payments Of Debt | $0 | $5,824,326 | $0 | - |
| Net Long Term Debt Issuance | $0 | $5,824,326 | $0 | - |
| Long Term Debt Issuance | $0 | $5,824,326 | $0 | - |
| Net Investment Purchase And Sale | $82,085 | $-1,876,253 | $7,449,896 | $-2,369,280 |
| Sale Of Investment | $6,034,355 | $5,466,977 | $10,445,884 | $7,500,000 |
| Purchase Of Investment | $-5,952,270 | $-7,343,230 | $-2,995,988 | $-9,869,280 |
| Change In Working Capital | $660,795 | $754,526 | $-143,209 | $-321,169 |
| Change In Other Working Capital | $896,466 | $344,869 | $91,918 | $-257,462 |
| Change In Payables And Accrued Expense | $538,210 | $179,655 | $-206,899 | $-2,607 |
| Change In Accrued Expense | $223,759 | $359,837 | $444,269 | $245,521 |
| Change In Interest Payable | $-5,373 | $107,173 | $0 | - |
| Change In Payable | $314,451 | $-180,182 | $-651,168 | $-248,128 |
| Change In Account Payable | $314,451 | $-180,182 | $-651,168 | $-248,128 |
| Change In Prepaid Assets | $83,964 | $24,742 | $64,902 | $-13,925 |
| Change In Receivables | $-857,845 | $205,260 | $-93,130 | $-47,175 |
| Changes In Account Receivables | $-846,964 | $219,425 | $-141,332 | $-83,265 |
| Other Non Cash Items | $48,697 | $63,021 | - | - |
| Stock Based Compensation | $930,183 | $1,126,279 | $1,244,121 | $1,888,944 |
| Amortization Of Securities | $-24,169 | $-71,057 | $-53,032 | $33,790 |
| Net Foreign Currency Exchange Gain Loss | $46,901 | $22,561 | $38,418 | $49,918 |
| Gain Loss On Sale Of Business | $0 | $-60,977 | $-1,017,592 | $0 |
| Net Income From Continuing Operations | $-7,364,628 | $-5,809,159 | $-6,795,461 | $-9,735,258 |
| Earnings Losses From Equity Investments | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-07-14